About Shanghai MicroPort Endovascular MedTech(Group)Co.,Ltd. Company

The company was incorporated in the Shanghai International Medical Park in 2012, and the first batch was listed on the Science and Technology Innovation Board in 2019. It is a national high-tech enterprise and the first batch of specialized, special and new “little giant” enterprises in the country. The company focuses on R&D, production, sales and service of aortic and peripheral vascular interventional medical devices. The company's domestic market share for intra-aortic intervention products reached 29%, ranking first in the Chinese market, and its international business covered 28 countries and regions in Europe, Latin America, Southeast Asia, etc. The company's products include aortic and abdominal aortic laminating stents, intraoperative stents, pharmaceutical balloon dilatation catheters, peripheral vascular stents, balloon dilatation catheters, etc. Corporate honors: It won the “2018 Shanghai Science and Technology Little Giant Enterprise” qualification, was selected as the “2017 Shanghai Brand Cultivation Demonstration Enterprise” and “2018 Advanced Unit for Work Safety”, and was recognized as a Shanghai Key Advantage Enterprise, Shanghai High-tech Enterprise, the first batch of specialized and new “Little Giant” enterprises in the country, Shanghai Enterprise Technology Center, Multinational R&D Center, AAA credit enterprise, etc., and won honors such as the 3rd Pudong New Area Quality Gold Award, Shanghai Quality Management Award, Shanghai Quality Benchmark, Shanghai Brand, etc.